Ela2 mutations and clinical manifestations in familial congenital neutropenia

Journal of Pediatric Hematology/Oncology

Volumn 31, Issue 5, 2009, Pages 319-324

  Shiohara, Masaaki ^a   Shigemura, Tomonari ^a   Saito, Shoji ^a   Tanaka, Miyuki ^a   Yanagisawa, Ryu ^a   Sakashita, Kazuo ^a   Asada, Hiroshi ^b   Ishii, Eizaburo ^c   Koike, Kazutoshi ^d   Chin, Motoaki ^e   Kobayashi, Masao ^f   Koike, Kenichi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Sogo Iwaki Kyouritsu Hospital   (Japan)

^c NAGANO CHILDREN'S HOSPITAL   (Japan)

^d Ibaragi Children's Hospital   (Japan)

^e NIHON UNIVERSITY   (Japan)

^f HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Neutropenia; Neutrophil elastase; Neutrophil specific granule protein

Indexed keywords

ANTIBIOTIC AGENT; CATHELICIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE; COTRIMOXAZOLE; ERYTHROMYCIN; GENOMIC DNA; GRANULOCYTE COLONY STIMULATING FACTOR; LEUKOCYTE ELASTASE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG; ANTIMICROBIAL CATIONIC PEPTIDE; CAP18 LIPOPOLYSACCHARIDE BINDING PROTEIN; CAP18 LIPOPOLYSACCHARIDE-BINDING PROTEIN;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL INFECTION; BONE MARROW; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DNA EXTRACTION; FAMILIAL CONGENITAL NEUTROPENIA; FAMILIAL DISEASE; FEMALE; FLOW CYTOMETRY; GENE AMPLIFICATION; GENE SEQUENCE; HETEROZYGOSITY; HUMAN; MALE; MISSENSE MUTATION; NEUTROPENIA; NONSENSE MUTATION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; ADOLESCENT; CYTOLOGY; FAMILY HEALTH; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; METABOLISM; NEUTROPHIL; PHYSIOLOGY; POINT MUTATION; RISK FACTOR;

ADOLESCENT; ADULT; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; FAMILY HEALTH; FEMALE; FLOW CYTOMETRY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEUKOCYTE ELASTASE; MALE; NEUTROPENIA; NEUTROPHILS; POINT MUTATION; POLYMERASE CHAIN REACTION; RISK FACTORS; YOUNG ADULT;

EID: 66149123032     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3181984dbe     Document Type: Article

References (25)

1. Ancliff PJ. Congenital neutropenia. Blood Rev. 2003;17: 209-216.
2. Welte K, Zeidler C, Dale DC. Severe congenital neutropenia. Semin Hematol. 2006;43:189-195.
3. Boxer LA, Newburger PE. A molecular classification of congenital neutropenia syndromes. Pediatr Blood Cancer. 2007; 49:609-614.
4. Horwitz M, Benson KF, Person RE, et al. Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis. Nat Genet. 1999;23:433-436.
5. Dale DC, Person RE, Bolyard AA, et al. Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutro-penia. Blood. 2000;96:2317-2322.
6. Ancliff PA, Gale RE, Liesner R, et al. Mutations in the ELA2 gene encoding neutrophil elastase are present in most patients with sporadic severe congenital neutropenia but only in some patients with the familial form of the disease. Blood. 2001; 98:2645-2650.
7. Horwitz MS, Duan Z, Korkmaz B, et al. Neutrophil elastase in cyclic and severe congenital neutropenia. Blood. 2007;109: 1817-1824.
8. Bohn G, Welte K, Klein C. Severe congenital neutropenia: new genes explain an old disease. Curr Opin Rheumatol. 2007;19: 644-650.
9. Person RE, Li FQ, Duan Z, et al. Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2. Nat Genet. 2003;34:308-312.
10. Klein C, Grudzien M, Appaswamy G, et al. HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nat Genet. 2007;39:86-92.
11. Ishikawa N, Okada S, Miki M, et al. Neurodevelopmental abnormalities associated with severe congenital neutropenia due to the B86X mutation in the HAX1 gene. J Med Genet. 2008;45:802-807.
12. Tanaka M, Gombart AF, Koeffler HP, et al. Expression of bactericidal/permeability-increasing protein requires C/EBPε. Int J Hematol. 2007;85:304-311.
13. Borregaard N, Cowland JB. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood. 1997;89: 3503-3521.
14. Kobayashi M, Sato T, Kawaguchi H, et al. Efficacy of prophylactic use of trimethoprim-sulfamethoxazole in autoimmune neutropenia in infancy. J Pediatr Hematol Oncol. 2003;25:553-557.
15. De Backer J, Loeys B, Leroy B, et al. Utility of molecular analyses in the exploration of extreme intrafamilial variability in the Marfan syndrome. Clin Genet. 2007;72: 188-198.
16. Schulze-Bahr E, Wedekind H, Haverkamp W, et al. The LQT syndromes-current status of molecular mechanisms. Z Kardiol. 1999;88:245-254.
17. Jenssen H, Hamill P, Hanock REW. Peptide antimicrobial agents. Clin Microbiol Rev. 2006;19:491-511.
18. Gombart AF, Shiohara M, Kwok SH, et al. Neutrophilspecific granule deficiency: homozygous recessive inheritance of a frameshift mutation in the gene encoding transcription factor CCAAT/enhancer binding protein-ε. Blood. 2001;97: 2561-2567.
19. Shiohara M, Gombart AF, Sekiguchi Y, et al. Phenotypic and functional alterations of peripheral blood monocytes in neutrophil-specific granule deficiency. J Leukoc Biol. 2004;75: 190-197.
20. Karlsson J, Carlsson G, Ramme KG, et al. Low plasma levels of the protein pro-LL-37 as an early indication of severe disease in patients with chronic neutropenia. Br J Haematol. 2007;137:166-169.
21. Borregaard N, Theilgaard-Monch K, Sorensen OE, et al. Regulation of human neutrophil granule protein expression. Curr Opin Hematol. 2001;8:23-27.
22. Putsep K, Carlsson G, Boman HG, et al. Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Lancet. 2002;360:1144-1149.
23. Donini M, Fontana S, Savoldi G, et al. G-CSF treatment of severe congenital neutropenia reverses neutropenia but does not correct the underlying functional deficiency of the neutrophil in defending against microorganisms. Blood. 2007; 109:4716-4723.
24. Karlsson J, Carlsson G, Larne O, et al. Vitamin D3 induces pro-LL-37 expression in myeloid precursors from patients with severe congenital neutropenia. J Leukoc Biol. 2008;84:1279-1286.
25. Gombart AF, O'Kelly J, Saito T, et al. Regulation of the CAMP gene by 1,25(OH)2D3 in various tissues. J Steroid Biochem Mol Biol. 2007;103:552-557.